Kyoji Tsuchikama[Author] - Search Results

Year	Number of Results
2005	1
2006	1
2007	1
2008	1
2009	1
2011	3
2012	2
2013	1
2015	1
2016	2
2017	2
2018	2
2019	2
2020	4
2021	2
2022	4
2024	1

1

Antibody-drug conjugates: recent advances in conjugation and linker chemistries.

Tsuchikama K, An Z. Tsuchikama K, et al. Protein Cell. 2018 Jan;9(1):33-46. doi: 10.1007/s13238-016-0323-0. Epub 2016 Oct 14. Protein Cell. 2018. PMID: 27743348 Free PMC article. Review.

2

Exploring the next generation of antibody-drug conjugates.

Tsuchikama K, Anami Y, Ha SYY, Yamazaki CM. Tsuchikama K, et al. Nat Rev Clin Oncol. 2024 Mar;21(3):203-223. doi: 10.1038/s41571-023-00850-2. Epub 2024 Jan 8. Nat Rev Clin Oncol. 2024. PMID: 38191923 Review.

3

Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance.

Yamazaki CM, Yamaguchi A, Anami Y, Xiong W, Otani Y, Lee J, Ueno NT, Zhang N, An Z, Tsuchikama K. Yamazaki CM, et al. Among authors: tsuchikama k. Nat Commun. 2021 Jun 10;12(1):3528. doi: 10.1038/s41467-021-23793-7. Nat Commun. 2021. PMID: 34112795 Free PMC article.

4

An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates.

Ha SYY, Anami Y, Yamazaki CM, Xiong W, Haase CM, Olson SD, Lee J, Ueno NT, Zhang N, An Z, Tsuchikama K. Ha SYY, et al. Among authors: tsuchikama k. Mol Cancer Ther. 2022 Sep 6;21(9):1449-1461. doi: 10.1158/1535-7163.MCT-22-0362. Mol Cancer Ther. 2022. PMID: 35793453 Free PMC article.

5

Transglutaminase-Mediated Conjugations.

Anami Y, Tsuchikama K. Anami Y, et al. Among authors: tsuchikama k. Methods Mol Biol. 2020;2078:71-82. doi: 10.1007/978-1-4939-9929-3_5. Methods Mol Biol. 2020. PMID: 31643050

6

[Novel Chemical Linkers for Next-generation Antibody-drug Conjugates(ADCs)].

Tsuchikama K. Tsuchikama K. Yakugaku Zasshi. 2019;139(2):209-219. doi: 10.1248/yakushi.18-00169-3. Yakugaku Zasshi. 2019. PMID: 30713230 Free article. Review. Japanese.

7

Homogeneous antibody-angiopep 2 conjugates for effective brain targeting.

Anami Y, Xiong W, Yamaguchi A, Yamazaki CM, Zhang N, An Z, Tsuchikama K. Anami Y, et al. Among authors: tsuchikama k. RSC Adv. 2022 Jan 26;12(6):3359-3364. doi: 10.1039/d1ra08131d. eCollection 2022 Jan 24. RSC Adv. 2022. PMID: 35425350 Free PMC article.

8

Recent advances in enantioselective [2 + 2 + 2] cycloaddition.

Shibata T, Tsuchikama K. Shibata T, et al. Among authors: tsuchikama k. Org Biomol Chem. 2008 Apr 21;6(8):1317-23. doi: 10.1039/b720031e. Epub 2008 Mar 12. Org Biomol Chem. 2008. PMID: 18385836 Review.

9

Glycation Reactivity of a Quorum-Sensing Signaling Molecule.

Tsuchikama K, Gooyit M, Harris TL, Zhu J, Globisch D, Kaufmann GF, Janda KD. Tsuchikama K, et al. Angew Chem Int Ed Engl. 2016 Mar 14;55(12):4002-6. doi: 10.1002/anie.201511911. Epub 2016 Feb 17. Angew Chem Int Ed Engl. 2016. PMID: 26890076 Free PMC article.

10

Homogeneity of antibody-drug conjugates critically impacts the therapeutic efficacy in brain tumors.

Anami Y, Otani Y, Xiong W, Ha SYY, Yamaguchi A, Rivera-Caraballo KA, Zhang N, An Z, Kaur B, Tsuchikama K. Anami Y, et al. Among authors: tsuchikama k. Cell Rep. 2022 May 24;39(8):110839. doi: 10.1016/j.celrep.2022.110839. Cell Rep. 2022. PMID: 35613589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year